世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

経カテーテル治療:手術と心臓弁市場

Transcatheter Treatment: Procedures and Heart Valve Market

 

出版社 出版年月電子版価格 ページ数
BCC Research
BCCリサーチ
2019年2月US$5,500
シングルユーザライセンス
164

サマリー

この調査レポートは経カテーテル治療市場を分析・予測したBCC Researchの市場調査報告書です。

Overview

Report Scope:

Transcatheter treatment includes procedure types such as TAVR, TAVI, TMVR, and TMVI. Transcatheter procedure approaches include transfemoral, transapical and transaortic procedures. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for transcatheter treatment for heart valve diseases. The format of this study includes the following -
- Detailed description, including demographics and cost burden, of heart valve diseases (e.g., valvular stenosis and regurgitation) and transcatheter procedure approaches (e.g., transfemoral, transapical and transaortic.)
- Detailed description and analysis of transcatheter treatments devices including TAVR, TAVI, TMVR, and TMVI devices.
- Market characterization, unmet need, market size, and segmentation (by region and treatment).
- Market drivers and restraints.
- Detailed market projections through 2023.
- Competition and market shares.
- Key marketed and pipeline (R&D) products along with information about their regulatory status.
- Strategic landscape (mergers and acquisitions).
- Regulatory structure.
- Pricing and reimbursement.
- Observations and conclusions on the future of transcatheter treatment.
- Profiles of market participants and associations.

Report Includes:

- 28 data tables and 25 additional tables
- An overview of the global market for transcatheter treatment technologies
- Analyses of global market trends, with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Analyses of the market by procedure segments, treatment approaches, and by region
- Detailed market sizing and analyses of the various transcatheter devices and technologies in use or under development
- Description of qualitative and quantitative factors that are driving the global market
- Description of key marketed and pipeline devices and technologies
- Profiles of major companies of the industry including, Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., Vascular Innovations Co. Ltd. and Valcare Inc.



目次

Table of Contents

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Structural Heart Valve Disease
Structural Heart Disease
Spectrum of Structural Heart Disease
Valvular Heart Disease
Symptoms and Risk Factors of Structural Heart Disease
Causes of Structural Heart Disease
Rheumatic Fever
Mitral Valve Prolapse
Peripheral Artery Disease
Cardiovascular Disease
Aortic Aneurysm
Obesity
Diagnosis of Structural Heart Disease
Treatment of Structural Heart Disease
Management Through Medication
Surgical Intervention: Heart Valve Repair and Replacement
Tobacco Smoking and Heart Disease
Aging, Gender, and Structural Heart Diseases
Global Demographics
U.S. Demographics
European Demographics
Japanese Demographics
Current Challenges and Future Directions
Chapter 4 Aortic Valve Disease
Disease Overview
Types of Aortic Stenosis
Acquired Aortic Stenosis
Congenital Aortic Stenosis
Mild and Moderate Aortic Stenosis
Severe Aortic Stenosis
Asymptomatic Aortic Stenosis
Symptomatic Aortic Stenosis
Causes, Risk Factors, and Symptoms
Causes
Symptoms
Risk Factors
Epidemiology and Economic Burden
Diagnosis
Standard Doppler Echocardiography
Multimodality Imaging
Other Techniques
Treatment
Open Surgical Treatment (SAVR)
Transcatheter Treatment (TAVR/TAVI)
Aortic Valve Repair Versus Aortic Valve Replacement
Types of Transcatheter Approaches
Open Surgical Repair (SAVR) Versus Transcatheter Treatment (TAVR/TAVI)
TAVR and TAVI Complications
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Self-expandable Versus Balloon-expandable Devices
Unmet Need
Current Challenges and Future Developments
Chapter 5 Mitral Valve Disease
Disease Overview
Types of Mitral Regurgitation
Degenerative Mitral Regurgitation
Functional Mitral Regurgitation
Mild and Moderate Mitral Stenosis
Severe Mitral Stenosis
Asymptomatic Mitral Stenosis
Symptomatic Mitral Stenosis
Causes, Risk Factors, and Symptoms
Causes
Symptoms
Risk Factors
Epidemiology and Economic Burden
Diagnosis
Standard Echocardiography
Multimodality Imaging
Other Techniques
Treatment
Open Surgical Treatment (SMVR)
Transcatheter Treatment (TMVR and TMVI)
Mitral Valve Repair Versus Mitral Valve Replacement
Types of Transcatheter Approaches
Open Surgery (SMVR) Versus Transcatheter Treatment (TMVR/TMVI)
TMVR Complications
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Other Less Invasive (MIS) Mitral Valve Technologies
Unmet Need
Current Challenges and Future Developments
Chapter 6 Market Size and Growth Analysis
Market Size and Growth Analysis
Market Size and Growth Analysis, by Region
Market Size and Growth Analysis, by Segment
Market Size and Growth Analysis, by Procedure Approach
Market Size and Growth Analysis, by Procedure (TAVR/TAVI and TMVR)
Heart Valve Market: Traditional Heart Valves (Tissue Heart Valves and Mechanical Heart Valves) Versus Transcatheter Heart Valves
Market Growth Drivers and Restraints
Market Growth Drivers
Market Restraints
Chapter 7 Competitive Landscape in Transcatheter Treatment Devices Market
Competitive Landscape in Transcatheter Treatment Devices Market
Chapter 8 Market Strategies in the Transcatheter Treatment Devices Market
Market Consolidation in Cardiovascular Devices Market
Mergers and Acquisitions in Transcatheter Treatment Devices Market
Recent Mergers and Acquisitions
Venus Medtech Acquired Intervalve Inc.
LivaNova PLC Acquired Caisson Interventional LLC
Boston Scientific Acquired Symetis SA
Boston Scientific Acquired Neovasc’s Advanced Biological Tissue Manufacturing Assets along with 15% Stake in Neovasc Inc.
Edwards Lifesciences Acquired Valtech Cardio Ltd.
Venus Medtech Inc. Acquired Transcatheter Technologies’ Technology Portfolio
Medtronic Acquired Twelve Inc.
Abbott Acquired Tendyne Holdings
Edwards Lifesciences Acquired CardiAQ Valve Technologies Inc.
Micro Interventional Devices Acquired Endovalve Inc.
Boston Scientific Acquired Sadra Medical Inc.
LoneStar Heart Acquired Cardiopolymers Inc.
Abbott Laboratories Acquired Evalve Inc.
Medtronic Acquired Ventor Technologies Ltd.
The Bracco Group acquired Heart Leaflet Technologies Inc. (HLT)
Minority Stakes and Future Options to Acquire
Abbott Laboratories Secures an Option to Buy Cephea Valve Technologies Inc.
Sorin Acquired Minority Stake in HighLife SAS
Boston Scientific Secures an Option to Buy MValve Technologies Ltd.
Sorin Group Acquired Minority Stake in Cardiosolutions Inc.
Future Strategic Landscape
Chapter 9 Regulatory Structure: Medical Devices
Regulatory Background
Regulatory Systems for Medical Devices, by Region
U.S.
European Union (EU)
Japan
Chapter 10 Pricing and Reimbursement: Medical Devices
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices, by Region
U.S.
Europe
Japan
Chapter 11 Conclusions?Outlook for Transcatheter Treatment Devices
Major Developments Influencing the Market
Technological Developments
Demographic and Economic Trends
Changing Structure of the Healthcare Industry
Long-term Outlook for Transcatheter Treatments
Chapter 12 Company Profiles
ABBOTT LABORATORIES
BIOTRONIK
BOSTON SCIENTIFIC CORP.
BRACCO SPA
BRAILE BIOMEDICA
CARDIAC DIMENSIONS INC.
CEPHEA VALVE TECHNOLOGIES INC.
COLIBRI HEART VALVE LLC
DIRECT FLOW MEDICAL INC.
EDWARDS LIFESCIENCES CORP.
GORMAN CARDIOVASCULAR RESEARCH GROUP
HANSEN MEDICAL INC. (SUBSIDIARY OF AURIS HEALTH INC.)
HIGHLIFE SAS
JENAVALVE TECHNOLOGY INC.
LABORATORIES INVALV
LIVANOVA PLC
LONESTAR HEART INC.
MEDTRONIC INC.
MICRO INTERVENTIONAL DEVICES INC.
MICROPORT SCIENTIFIC
MITRAGEN INC.
MITRALIX LTD.
MITRALTECH LTD.
MITRASSIST LTD.
MITRICARES SAS
MITRAL HEAL LTD.
MITRALIGN INC.
MVRX INC.
NAKOSTECH SARL
NAVIGATE CARDIAC STRUCTURES INC.
NEOVASC INC.
NEW VALVE TECHNOLOGY (NVT) AG
SINO MEDICAL SCIENCE TECHNOLOGY INC.
ST. JUDE MEDICAL INC. (SUBSIDIARY OF ABBOTT LABORATORIES)
TAU-PNU MEDICAL CO. LTD.
THUBRIKAR AORTIC VALVE INC.
TRANSCATHETER TECHNOLOGIES GMBH
TRANSMURAL SYSTEMS
VASCULAR INNOVATIONS CO. LTD.
VALCARE INC.
VALVEXCHANGE INC.
VENUS MEDTECH INC.
Chapter 13 Appendix A: List of Acronyms
Chapter 14 Appendix B: Professional Organizations
American Heart Association
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Centers for Medicare & Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or USFDA)
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Network for Excellence in Health Innovation (NEHI)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Health Organization (WHO)

List of Tables

List of Tables
Summary Table : Global Market for Transcatheter Treatment Devices, by Region, Through 2023
Table 1 : Scope of Structural Heart Diseases
Table 2 : Leading Peripheral Vascular Disease Conditions
Table 3 : Global Prevalence of Peripheral Artery Disease, Through 2021
Table 4 : Global Incidence Share of Hypertension, by Patient Group, 2017
Table 5 : Global Prevalence of Angina Pectoris and Stroke, by Survivors, Through 2030
Table 6 : Global Prevalence of Congestive Heart Failure and Stroke, by Type, Through 2030
Table 7 : Epidemiology, AAA vs. TAA
Table 8 : Global vs. U.S. Prevalence of AAA, Through 2023
Table 9 : BMI Calculation
Table 10 : BMI Categories Based on Increasing Health Risks
Table 11 : Trends in Obesity in the World’s Population, by Segment, Through 2021
Table 12 : U.S. Obesity and Severe Obesity vs. General Population, by Segment, Through 2021
Table 13 : Structural Heart Disease, Management Through Medication
Table 14 : Structural Heart Valve Disease Treatment Through Surgical Intervention
Table 15 : Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 16 : World Population, by Region, Through 2030
Table 17 : U.S. Population Estimates and Projections, by Age Group, Through 2030
Table 18 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
Table 19 : European Population Estimates and Projections, by Age Group, Through 2030
Table 20 : Japanese Population Estimates and Projections, by Age Group, Through 2030
Table 21 : Aortic Valve Area and Calcification Score, by Stage of Aortic Stenosis
Table 22 : Global vs. U.S. Prevalence of Aortic Stenosis, Through 2023
Table 23 : Global vs. U.S. Prevalence of Severe/Symptomatic Aortic Stenosis, Through 2023
Table 24 : Imaging Techniques for Aortic Stenosis Diagnosis
Table 25 : Types of Aortic Valve and Repair Techniques
Table 26 : Advantages and Challenges of TAVI vs. TAVR
Table 27 : TAVR Access Routes for Aortic Stenosis
Table 28 : Key Marketed Products in Transcatheter Aortic Valve Treatment
Table 29 : Key Pipeline/R&D Products in Transcatheter Aortic Valve Treatment
Table 30 : Mitral Valve Area, by Stage of Mitral Stenosis
Table 31 : Global vs. U.S. Prevalence of Mitral Regurgitation, Through 2023
Table 32 : Global vs. U.S. Prevalence of Severe/Symptomatic Mitral Regurgitation, Through 2023
Table 33 : Imaging Techniques for the Diagnosis of Mitral Valve Disease
Table 34 : Types of Mitral Valve Repair
Table 35 : Types of Mitral Valve and Repair Techniques
Table 36 : TMVI vs. TMVR, Advantages and Challenges
Table 37 : Key Marketed Products, Transcatheter Mitral Valve Treatment
Table 38 : Key Pipeline/R&D Products, Transcatheter Mitral Valve Treatment
Table 39 : Transcatheter Mitral Valve Treatment, Other Less Invasive (MIS) Mitral Valve Technologies
Table 40 : Global Market for Transcatheter Treatment Devices, by Region, Through 2023
Table 41 : Global Market for Transcatheter Treatment Devices, by Segment, Through 2023
Table 42 : Global Market for Transcatheter Treatments, by Procedure (TAVR/TAVI and TMVR), Through 2023
Table 43 : Global Market for Heart Valves, by Type of Valve, Through 2023
Table 44 : Global Market for Transcatheter Treatment Devices, by Leading Company, 2017
Table 45 : Key Strategic Deals in Transcatheter Treatments Market, 2008-2017
Table 46 : Other Key Strategic Deals (Minority Stakes and Future Options to Acquire) in Transcatheter Treatments Market, 2012-2015
Table 47 : Differences in Regulatory Approval in the U.S. and Europe
Table 48 : Transcatheter Aortic Valve Procedures, Billing and Reimbursement, U.S.
Table 49 : Operations on Aortic Valve, ICD-10 Procedure Code
Table 50 : Hospital Inpatient Procedures Utilizing MS-DRGs, National Average Reimbursement, CMS
Table 51 : Trends in Per Capita Real GDP Growth, by Region, 2014-2017
Table 52 : List of Acronyms

List of Figuresはメールでお送りいたします。データリソースまでお申し付けください。

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る